The power-point presentation addresses the present status and future prospects of biopesticides and biofertilizers in India with special reference to NE India. The market trends, demand & supply, public and private organizations involved, schemes under organic farming and establishment of fertilizer unit, market constrains, technology gap etc. are addressed in the presentation.

1. Prospects of Bio-formulations in
Indiawith special emphasis on N.E.
India
Gautam Handique, PhD
Scientist C
Advisory Department
Tocklai Tea Research Institute, Jorhat

2. Global scenario
Source: FiBL, 2021

3. State of organic
farming
in India
 Biogas (fermented organic manure) in
organic farming
 Revise syllabi of agrivarsities to meet the
needs of natural and organic farming

4. State of organic farming in India
Area under organic agriculture area in India
(in Thousand hectares)
Sikkim: 100% organic
(58,168 hectares)

5. Status of North East
India
State Area (in Ha) In transition (Ha)
Meghalaya 2,580 37,756
Assam 9,883 18,129
Nagaland 3,526 5,314
Arunachal 51 6,129
Manipur 158 5,240
Tripura 204 2,048
Mizoram 0 999
Total 16,402 75,615

6. Status of North East India
 Nearly 5.5 million ha of cultivated land;
OrFa barely covers 3%
 Approximately,18 lakhs ha of land in NER
can be classified as “Organic by Default”.
 The NER has the potential of contributing
20 lakh ha of agricultural land towards OrFa
 Crops: Assam Lemon, Joha Rice, Passion
fruit, Tea, Ginger, Cardamon, Chilli,
Pineapple, Oranges, Vegetables etc.

7. Bioformulations:
Where do we stand?

8. Biofertilizer
s
NF Azolla PSM VAM PGPR SSM
Biopesticides
Microbials Plants EPN Biochemica
l
Others

9. Global
Biofertilizer
Market,
2020
58.09
69.41 71.17 72.29
0
10
20
30
40
50
60
70
80
Area
under
biofertilizers
(Thousand
Ha)
Area under
biofertilizers from
2016-2019

10. Key Trends
 Biofertilizer market is expected to grow at
a CAGR of 10.1%
 Largest market: Europe; Fastest Growing:
North America
 Germany to convert 20% of the total
agricultural land into organic by 2030
 Major products: Rhizobium, Azotobacter,
Azospirillum, BGA, PSB, Mycorrhiza

11. Global
Biopesticid
e Market,
2020
Area under
biopesticides
from 2016-2019
13.5
14.4
15.6
16.5
0
2
4
6
8
10
12
14
16
18
Area
under
biopesticides
(Million
Ha)

12. Key Trends
 EU plans to reduce the use 505 chemical
pesticides
 Biopesticide market is expected to grow at a
CAGR of 15.1%
 Largest market: North America; Fastest
Growing: South America
 Emerging economies in Asia-Pacific are likely
to take the lead in adopting biopesticides
 Consumption of biopesticides highest for
cereal crops with gradual increase in oilseeds
 Major products:
Bioherbicides, Bioinsecticides, Biofungicides,
Other Products

13.  Worldwide, approximately 1400
biopesticide products are being sold
 Bt formulations represent about 95%
of total microorganisms used.
Globally, 322 products of Bt are
generating annual revenue of $210
million
 Solid formulations have more
acceptance than liquid formulations
Key Trends

14. Scope
 The scope of bioformulations in agriculture
is fully aligned with market trends that
promote healthy eating and environmental
conservation
 Export oriented food and products from
India will have more stringent regulatory
frameworks and MRL issues from EU and
allied countries
 With increase in organic cultivation,
tremendous requirement of different
organic inputs

15.  At present, more than 350 registered
producers in India
 Average biofertilizer consumption is 45000
ton per annum, production almost half of it
Bio-fertilizers Estimated demand (ton)
Rhizobium 34,999
Azotobacter 1,45,953
Azospirillum 74,342
Blue-green
algae
2,51,378
P solubilizer 25,534

16. State-wise production of biofertilizers in India

17. Status of biopesticide use in
India
 Standardization & mass production:
Trichoderma, Pseudomonas,
Trichogramma, NPV and Bacillus
 The gross demand for a few
biopesticides are:
Biopesticide Demand
Trichogramma 690 million cards
Heliothis NPV (HNPV) 5293 million LE
Spodoptera NPV (SINPV) 3729 million LE
Trichoderma 2280 MT

18. Most consumed bio-pesticides in India
26%
18%
16%
9%
8%
8%
6%
5% 4%
Trichoderma viride
Pseudomonas
fluorescens
NPV (H)
Trichoderma
harzianum
Neem based
Beauveria bassiana
Azadirachtin

21.  There are currently 970 biopesticide
products registered with the CIB
 Out of these:
◦ Bacterial: 29%
◦ Fungal: 66%
◦ Viral: 4%
◦ Others (plant-based, pheromones): 1%
 Bioinsecticides account for about 70% of
the market
 T. viride is the most frequently utilised on
87 different crops, 70 soil-borne
diseases, and 18 foliar diseases

22. List of some biopesticides
registered as on July, 2021
 Bacillus thuringiensis
 Bacillus subtilis
 Trichoderma virde
 Trichoderma
harzianum
 Beauveria bassiana
 NPV of Helicoverpa
 NPV of Spodoptera
 Metarhizium
anisopliae
 Azadirachtin
 Triacontanol
 Paecilomyces
lilacinus
 P. flourescens
 Ampelomyces
quisqualis
 Verticilium lecanii
 Gossyplure
 Spinosad

23. Objectives of Bioformulation based
projects for funding
 Establish the bankability of mass
multiplication and application
 To serve as guidelines for extending
financial assistance to entrepreneurs
 To promote setting up of more bio-control
production units
 To disseminate widely the technology

24. What we can do?
 Agrivarsities and R&D institutes can
identify potential organisms, establish
their bioefficacies, develop
formulations and commercialize on
their own as a “brand”
 Sell the technology to
firms/entrepreneurs for
commercialization on non exclusive
basis
 Youth training for entepreneurship
 Farmers’ training

25. What the Government can do?
 Registration guidelines can be simplified
 Applications can be processed on
priority basis
 Commercialization can be permitted
during provisional registration
 Capacity building of the unemployed
youth leading to meaningful employment
followed by financial aids to set up units

26.  PKVY: Assistance of Rs. 50K/ha for 3
years is provided, of which Rs. 31K
(62%) is given to the farmers directly
through DBT
 MOVCDNER: Assistance of Rs. 25K/ha
for 3 years for both on-farm & off-farm
organic inputs
 CISS: Government provides 100%
assistance to Government agencies up
to a maximum limit of Rs.160.00 lakh/
unit for setting up bio-fertilizer units of
200 ton/ annum capacity
Scope under various Govt.
schemes

27.  To establish bio fertilisers and bio
pesticides production units
 To convert organic waste into plant-
nutrient resources
 Individuals, group of
farmers/growers, proprietary and
partnership firms, co-operatives,
fertilizer industry
Scope under NABARD

28. Scope under
NSDC
http://www.asci-india.com/

29. Success stories
NBAIM, UP
Biopesticide
s
Eco-Green
Eco-Pesticide
Biopulse
Green
Biofertilizers
Bio NPK
Biogrow
Biophos
Bio Potash

30. Product Composition Institute
Coneem
Cow urine based herbal
formulation
NCIPM
NutMagic
Pseudomonas + Bacillus +
Rhizobium
DGR
Halo-PSB PSB
CSSRI
Halo-Azo Azotobacter
Arka Actino+ 3 Streptomyces spp. IIHR
PUSA
Sampoorn
Consortium of 3 bacteria
IARI
PUSA
Biophos
PSB
Biofor-PF-2
P. fluorescence + T.
harzianum
AAU
Biozin-PTB
P. aeruginosa + T.

31. IFFCO

32. Multiplex
 Founder: Dr. G.P. Shetty
 Location: Karnataka

34. Varsha Bioscience & Technology
India Pvt. Ltd.
 Founder: Dr. A. John
Peter
 Technology Tie-
ups:
1. TNAU
2. IIHR
3. NCL
4. ICFAI
 Location: Hyderabad

35. Prathibha Biotech Pvt. Ltd.

36. Source: The Internet

37. Monsut Chem
Industries
 Founder: Syed Abdul Suit
 Establishment: 2013
 3 units: Guwahati, Morigaon and
Goreswar
 Monsut Chem Industries produces
mainly organic fertilizers, synthetic
pesticides, micronutrient fertilizers
and different types of yield enhancer
 The Sentinel: “The success story of
Assam's new age entrepreneur Syed
Abdul Suit”

39.  One of the oldest and pioneering
producers of bioinputs
 Mukta: The 1st product. Developed by
AAU; Certified by NEIST and TTRI
 Other products:
Viricon-L
Pseudocon-L
Helocon-S
Termicon-M.A.
Bacilla-L
Orgaman

40. MD’s Organic
 Founder: Fr. Samir Ranjan Bordoloi
 Location: Cinnamara, Jorhat

41. A short glimpse of the unit
…..

42. Case study: Tea

43.  Assam has around 3,12,210 ha area
under tea which produced about
645.14 million kg of tea
 Some of the organic plantations are:
◦ Hatikhuli
◦ Banaspaty
◦ Deha
◦ Jamguri
◦ Charaideo Purbat
◦ Chota Tingrai
◦ Maud
•Partial conversion feasible at present

44. Factors
 Demand for chemical free tea
 Export commodity
 Regulation
 Blanket application of insecticides,
especially the synthetic pyrethroids
 Introduction of PPC
 Workers’ safety and welfare
 Secondary pest outbreak/tolerance
 Conserve biodiversity

45. The scenario
 Many MNCs are providing
bioformulations
 Major products include Trichoderma
viridae, T. harzianum, Bacillus subtilis,
Azotobacter, Azospirillum, Beauveria
bassiana, Metarhizium anisopliae, EPN
 Demand for pheromones, NPV and GV
for managing caterpillars and sucking
pests

46. Some
bioformulations
used
in
tea

47. TTRI: Formulations, IPM and
INM
 Extensive demand for Trichoderma by
the tea industry
 Effective against leaf and stem red
rust, blister blight, Fusarium die back,
charcoal stump rot, brown root rot
 Applied after HRP/LP/DS as a
protective spray
 Growth promoter, especially in young
tea (0-5 years age)
 Stress conditions

48. Works in progress
 Tea oil and tea saponin based
formulations
 Isolation and identification of EPN
from tea soils to develop a formulation
EPN

49.  INM: 25% replacement possible
 Explore the potential of Mermithid
nematode in pest management

50. Motivated?

51. Importance
 Principle of
Health
Fairness
Ecological Balance
Care
 Sustainability
 Entrepreneurship through proper
training to narrow the existing gap
between demand and supply

52. Barriers to commercialization
 It is mandatory for any bioformulation
to be registered with the CIB
 Manufacturers have to submit
information on composition, source,
bio efficacy, toxicology data,
packaging, and labelling while
applying for registration
 Private firms insist that R&D
organizations must develop this data
while developing the product itself
 Lack of these information delay the

53.  Many potent formulations are limited
to laboratory trials and limited field
trials
 Mixed results and mixed response
 Lack of consistency in performance
 Lack of awareness on its technical
know-how and use
 Quality control: Unethical producers
 Infrastructural costs for establishment
of a unit

54. Focus
 To explore PPP models for funding
 Training programme on
“Bioformulation based Business
Management” in collaboration with
external agencies
 Field demonstrations for the new
products to support commercial
launch
 Feedback from end users on the
product’s efficacy, quality, etc.